Semaglutide Linked to Age-Related Macular Degeneration Risk

By News Health
2 days Ago

(MedPage Today) — Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related macular degeneration (nAMD), according to a retrospective…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/115919

Author :

Publish date : 2025-06-05 15:48:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mum of boy with PPFIBP1 gene says finding others gave her 'strength'

Novel Anticoagulant Flops for Staving Off Graft Thrombosis in Dialysis Patients

AI-Directed Breast MRI Could Lead to Faster Scan Times Without Affecting Accuracy

Home Testing Doubles Cervical Cancer Screening in Safety-Net Population

Infectious Disease Docs Slam New COVID Vaccine Recommendations

Some Psych Meds Tied to Higher Future Risk of ALS